Hye-Jung Lim

Title: Hye-Jung Lim: Innovator in Pharmaceutical Composition

Introduction

Hye-Jung Lim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. His innovative work has led to the granting of a patent that showcases his expertise and dedication to advancing pharmaceutical technology.

Latest Patents

Hye-Jung Lim holds a patent for a "Melt-extruded release controlled pharmaceutical composition and oral dosage form comprising the same." This patent discloses a controlled release pharmaceutical composition that includes a melt-extruded pellet made from a water-insoluble ammonium methacrylate copolymer, a polyvinyl acetate, and an active ingredient. Additionally, it features a polymer coating layer that includes a water-insoluble ammonium methacrylate copolymer formed on the surface of the pellet, along with an oral formulation that incorporates the pharmaceutical composition. This innovation is crucial for improving the efficacy and delivery of medications.

Career Highlights

Throughout his career, Hye-Jung Lim has worked with prominent organizations in the biopharmaceutical sector. He has been associated with Samyang Biopharmaceutical Corporation and Samyang Biopharmaceuticals Corporation, where he has contributed to various projects aimed at enhancing drug formulations and delivery systems.

Collaborations

Hye-Jung Lim has collaborated with several professionals in his field, including Sang-Yeob Park and Kyung-Hee Kim. Their combined expertise has likely played a role in the successful development of innovative pharmaceutical solutions.

Conclusion

Hye-Jung Lim's contributions to the pharmaceutical industry through his patent and collaborations highlight his role as an innovator in controlled release formulations. His work continues to influence the development of effective drug delivery systems.